You are here: Industry Insights > colorectal cancer

News List

Bayer, BMS, Ono Pharma enter into clinical collaboration for colorectal cancer biospectrumasia
July 22, 2019
Under clinical collaboration agreement companies to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer
Trovagene Initiates Enrollment for KRAS-Mutated Colorectal Cancer Trial americanpharmaceuticalreview
July 10, 2019
Trovagene announced the initiation of patient enrollment of its Phase 1b/2 study of onvansertib in combination with FOLFIRI and Avastin® (bevacizumab) for second-line treatment of patients with metastatic colorectal cancer (mCRC) with a KRAS mutation (NCT
Researchers develop new prognostic test for colorectal cancer pharmatimes
March 08, 2019
High-risk stage two cancer patients could be identified more easily and accurately, due to a hopeful new prognostic method.
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients pharmafocusasia
February 19, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology .....
FDA approves consumer colorectal cancer test pharmaphorum
January 25, 2019
The FDA will allow consumer DNA testing company 23andMe to give customers reports on their risk of hereditary colorectal cancer.
Anemia Criteria Assist Decision on Type of Colorectal Cancer Screen drugs
January 04, 2019
In patients without broad-definition anemia and/or abdominal mass, flexible sigmoidoscopy (FS), instead of colonoscopy, may suffice to rule out colorectal cancer, according to a study published online Dec. 19 in the British Journal of Cancer.....
Long-Term Reduction in CRC Risk After Negative Colonoscopy drugs
January 02, 2019
For average-risk patients, a negative colonoscopy result is associated with a long-term reduction in the risk for colorectal cancer and related deaths, according to a study published online Dec. 17 in JAMA Internal Medicine.....
Type 2 Diabetes Linked to Colorectal Cancer Risk in Men drugs
December 06, 2018
Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the British Journal of Cancer.....
Finally! The 100% Chinese-produced Targeted Anti-cancer Drug Fruquintinib Developed by Hutchison MediPharma for 13 Years to be Marketed Caicai
September 07, 2018
The blockbuster targeted anti-cancer drug Fruquintinib that I’ve been following has finally achieved new significant progress recently.
ACS Updates Colorectal Cancer Screening to Start at Age 45 drugs
May 31, 2018
Colorectal cancer (CRC) screening should begin at age 45 for people at average risk, according to updated guidelines from the American Cancer Society published online May 30 in CA: A Cancer Journal for Clinicians.

Previous page 1 2 3 Next page